EDBI Logo
|  
Flyout Menu

Category: Portfolio News

Portfolio News

Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy

Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced the successful completion of US$45 million Series B
  • 20 05 2025
  • |
Read More

Portfolio News

VFlowTech Secures USD $20.5 Million in its Latest Fundraising to Scale Long-Duration Energy Storage and Strengthen AI-Driven Energy Management

VFlowTech, a homegrown leader in long-duration energy storage solutions, has successfully raised USD $20.5 million in its latest funding round.
  • 16 05 2025
  • |
Read More

Portfolio News

Addepar Raises $230 Million at $3.25 Billion Valuation in Series G Investment Round

Addepar, a leading global technology and data platform that investment professionals rely on to make the most informed, data-driven investment decisions, announced today the
  • 16 05 2025
  • |
Read More

Portfolio News

Singapore biotech firm Mirxes launches IPO in Hong Kong to raise HK$1 billion

Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks to raise HK$1.09 billion
  • 15 05 2025
  • |
Read More

Portfolio News

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, today announced its launch with
  • 05 03 2025
  • |
Read More

Portfolio News

Island Announces Participation of Singapore-based Global Investor EDBI in its Series D Round to Accelerate Expansion Plans in the Asia-Pacific Region

Island, the Enterprise Browser company, announced the participation of EDBI, the strategic investment arm of the Singapore Economic Development Board, in its previously announced
  • 11 12 2024
  • |
Read More

Portfolio News

Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological Disorders

Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
  • 16 10 2024
  • |
Read More

Portfolio News

A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore

Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Accelerate Talent Development
  • 02 10 2024
  • |
Read More

Portfolio News

What EDBI’s investment means for Arta’s international plans

  • 11 09 2024
  • |
Read More

Portfolio News

Riverlane raises $75 million to meet surging global demand for quantum error correction technology

  • 06 08 2024
  • |
Read More

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now

Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.

About EDBI

Team

Portfolio

News and Insights

Careers

Contact Us

Linkedin Youtube

© 2025 EDBI. All rights reserved.